Key takeaway: Insecticides (India) Limited provided an investor presentation detailing its Q1 FY 2027 results, highlighting a revenue from operations of INR 611.52 crore, a decrease of 12% year-over-year. The gross profit was reported at INR 193.16 crore, reflecting a 4% decline, with a gross profit margin of 31.6%. EBITDA also saw a reduction of 20%, amounting to INR 67.61 crore, resulting in an EBITDA margin of 11.1%. Profit after tax (PAT) decreased by 24% to INR 43.87 crore, with a PAT margin of 7.2%. The presentation emphasized the company's strategic focus on premium products, innovation, and expanding its distribution network, alongside a commitment to sustainability and digital initiatives. Management noted the importance of collaborations and acquisitions in enhancing market presence and product offerings.

Key takeaway: Insecticides (India) Limited held its Q4 and FY26 Earnings Conference Call on May 28, 2026, where management discussed the company's performance and strategic initiatives. Managing Director Rajesh Kumar Aggarwal highlighted a 19% growth in Q4, driven by both B2C and B2B segments, and a full-year growth of over 7%. The company faced challenges due to rising raw material prices and geopolitical tensions but maintained operational readiness and inventory levels. Management emphasized a focus on premiumization, with over 25 new product launches in the last three years, and partnerships with global firms like Nissan and Corteva. CFO Sandeep Aggarwal reported a slight decline in PAT due to increased tax provisions, while revenue from operations rose to INR 2,140 crores. The company aims to enhance its distribution network and brand presence, particularly through its new subsidiary, Kaeros. Management expressed cautious optimism for FY27, anticipating improved demand as the monsoon season approaches.

Key takeaway: Insecticides (India) Limited's investor presentation for Q4 and FY 2026 detailed the company's financial performance, reporting a revenue increase to INR 2,140 crore, a 7% rise from the previous year. The presentation highlighted a shift towards premium products, with B2C revenue from premium products increasing from 51% in FY25 to 58% in FY26. Gross profit margin improved to 31.5%, while EBITDA margin rose to 10.6%. The company emphasized its extensive distribution network, reaching over 75 lakh farmers through 8,500 distributors. Management noted ongoing investments in R&D and international collaborations, particularly with Corteva Agriscience, to enhance product offerings. The presentation also outlined the company's commitment to sustainability and operational efficiency, with a focus on reducing its carbon footprint and improving working capital ratios. Overall, the document provided a comprehensive overview of the company's strategic initiatives and financial health.

Key takeaway: Insecticides (India) Limited held its Q3 FY '26 Earnings Conference Call on January 30, 2026, where management reported an 8% growth despite a challenging operating environment characterized by weak farmer activities and weather issues. The growth was primarily volume-led, with the B2B segment contributing significantly. Management noted that gross margins moderated due to a higher share of B2B sales and limited pricing power. New product launches, including SPARCLE, received positive farmer acceptance, and the company launched five new products in the first nine months. Management highlighted a cautious approach for Q4, anticipating continued margin pressure and a focus on maintaining market share. The company aims for sustainable growth of 8% to 10% over the next two to three years, supported by strategic initiatives and product launches. Overall, the management emphasized resilience and long-term competitiveness despite current market challenges.